Skip links
Companies
› United States › NEUROCRINE BIOSCIENCES, INC.
NEUROCRINE BIOSCIENCES, INC. logo

NEUROCRINE BIOSCIENCES, INC.

Inactive

in

Registration No.
1521912
Incorporation Date
1992-01-17
Company Type
Not disclosed
Address
SAN DIEGO, United States
Website
neurocrine.com/
Source: California Secretary of State — bizfile Online

NEUROCRINE BIOSCIENCES, INC. is a registered legal entity registered in United States under 1521912, and its current status with California Secretary of State — bizfile Online is inactive. The company was incorporated on 17 January 1992 and lists its registered address as SAN DIEGO, United States. 3 shareholders are on record for NEUROCRINE BIOSCIENCES, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 3 October 2026.

Data Provenance
This record is sourced directly from official government registries, including California Secretary of State — bizfile Online.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

3

Three shareholders are currently on record for NEUROCRINE BIOSCIENCES, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Vanguard Group Inc, holding 13.3% — the largest recorded stake — followed by iShares Trust-iShares Core S&P Mid-Cap ETF at 4.4%; the remaining 1 shareholder shown holds smaller stakes.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
Vanguard Group Inc 13.3% California Secretary of State — bizfile Online
iShares Trust-iShares Core S&P Mid-Cap ETF 4.4% California Secretary of State — bizfile Online
iShares Trust-iShares Core S&P Mid-Cap ETF 4.3% California Secretary of State — bizfile Online

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Ceo & Director of NEUROCRINE BIOSCIENCES, INC. currently on record is Kyle W. Gano Ph.d.; five officers are currently on record for NEUROCRINE BIOSCIENCES, INC., filed with California Secretary of State — bizfile Online.

The register reports 21 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at NEUROCRINE BIOSCIENCES, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

KW
Kyle W. Gano Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Ceo & Director

EW
Eiry Wyn Roberts M.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Medical Officer

JO
Jude Onyia Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Scientific Officer

ID
Ingrid Delaet Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Regulatory Officer

DM
Darin M. Lippoldt Esq. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Legal Officer & Corporate Secretary

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

NEUROCRINE BIOSCIENCES, INC. has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 3 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 5 subsidiaries span United States, United Kingdom, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 5 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Ultimate HQ
NEUROCRINE BIOSCIENCES, INC.
United States
IMMEDICA GROUP LIMITED+ subsidiaries
United KingdomGB 09846650

NEUROCRINE UK LIMITED
United KingdomGB 14133552

Soleno Therapeutics, Inc.+ subsidiaries
United StatesUS CA 3083882

Neurocrine Switzerland GmbH
SwitzerlandCH CHE-288.406.862

Neurocrine Continental, Inc.
United StatesUS CA 3860202

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on NEUROCRINE BIOSCIENCES, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns NEUROCRINE BIOSCIENCES, INC.?

Three shareholders are currently on record for NEUROCRINE BIOSCIENCES, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 13.3% — the largest recorded stake — followed by iShares Trust-iShares Core S&P Mid-Cap ETF at 4.4%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is NEUROCRINE BIOSCIENCES, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for NEUROCRINE BIOSCIENCES, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does NEUROCRINE BIOSCIENCES, INC. have on record?

3 shareholders are shown on record for NEUROCRINE BIOSCIENCES, INC..

What is NEUROCRINE BIOSCIENCES, INC.'s company registration number?

NEUROCRINE BIOSCIENCES, INC.'s registration number is 1521912, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is inactive.

Is NEUROCRINE BIOSCIENCES, INC. still an active company?

NEUROCRINE BIOSCIENCES, INC.'s status on California Secretary of State — bizfile Online is listed as inactive, not currently active.

When was NEUROCRINE BIOSCIENCES, INC. incorporated?

NEUROCRINE BIOSCIENCES, INC. was incorporated on 17 January 1992, according to California Secretary of State — bizfile Online.

What is NEUROCRINE BIOSCIENCES, INC.'s registered address?

The registered address on file for NEUROCRINE BIOSCIENCES, INC. is SAN DIEGO, United States.

Who are the officers/directors of NEUROCRINE BIOSCIENCES, INC.?

The Ceo & Director of NEUROCRINE BIOSCIENCES, INC. currently on record is Kyle W. Gano Ph.d.; five officers are currently on record for NEUROCRINE BIOSCIENCES, INC., filed with California Secretary of State — bizfile Online. Management authority at NEUROCRINE BIOSCIENCES, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does NEUROCRINE BIOSCIENCES, INC. have a parent company or subsidiaries?

NEUROCRINE BIOSCIENCES, INC. has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 3 jurisdictions. Those 5 subsidiaries span United States, United Kingdom, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 5 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Can Zavia monitor changes to NEUROCRINE BIOSCIENCES, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to NEUROCRINE BIOSCIENCES, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access NEUROCRINE BIOSCIENCES, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like NEUROCRINE BIOSCIENCES, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 3 October 2026.

This website uses cookies to improve your web experience.